
RNARNA
RNA Price
N/A

Novartis shares fall as profit lags estimates; downside from Entresto patent loss to continue
Shares in Swiss drugmaker Novartis were seen down 3.3% in pre-market trade on Tuesday after the company reported third-quarter profitability below ...
Oct 28, 2025
3 min read
by Invezz

Europe bulletin: UK-Turkey jet deal, market gains, and Novartis’ $12B RNA bet
European markets opened the week on a cautiously optimistic note, closing mostly higher on Monday as investors weighed key geopolitical and corpora...
Oct 27, 2025
3 min read
by Invezz

Is it too late to buy Avidity stock after Novartis deal?
Novartis (NYSE: NVS) revealed plans of acquiring Avidity Biosciences Inc (NASDAQ: RNA) in a $12 billion all-cash transaction – valuing each share o...
Oct 27, 2025
2 min read
by Invezz

Ionis Pharmaceuticals stock rockets 31% to new 52-week high on breakthrough news
Ionis Pharmaceuticals stock jumped 31% on Tuesday hitting a new 52-week high after breakthrough news that lit up investor interest and boosted conf...
Sep 2, 2025
2 min read
by Invezz

The Week’s 10 Biggest Funding Rounds: AI On Top Again, Led By xAI’s Massive Raise
The pace of large U.S. startup financing announcements was somewhat muted in a shortened Fourth of July workweek. There was, however, one big excep...
Jul 3, 2025
3 min read
by Crunchbase

The Week’s Biggest Funding Rounds: OpenAI Easily Tops Massive Week
This was a week right out of the free-spending days of 2021. Huge rounds were abundant — led by the biggest of them all as OpenAI’s massive $40 bil...
Apr 4, 2025
6 min read
by Crunchbase
